Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/121970
dc.contributor.author | Oliveira, Paulo A. |
---|---|
dc.contributor.author | Dalton, James A. R. |
dc.contributor.author | López-Cano, Marc |
dc.contributor.author | Ricarte, Adrià |
dc.contributor.author | Morató Arús, Xavier |
dc.contributor.author | Matheus, Filipe C. |
dc.contributor.author | Cunha, Andréia S. |
dc.contributor.author | Müller, Christa E. |
dc.contributor.author | Takahashi, Reinaldo N. |
dc.contributor.author | Fernández Dueñas, Víctor |
dc.contributor.author | Giraldo, Jesús |
dc.contributor.author | Prediger, Rui D. |
dc.contributor.author | Ciruela Alférez, Francisco |
dc.date | 2018-04-30T13:15:28Z |
dc.date | 2018-04-30T13:15:28Z |
dc.date | 2017-05-12 |
dc.date | 2018-04-30T13:15:28Z |
dc.identifier.citation | 2045-2322 |
dc.identifier.citation | 679437 |
dc.identifier.uri | http://hdl.handle.net/2445/121970 |
dc.format | 12 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Nature Publishing Group |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1038/s41598-017-02037-z |
dc.relation | Scientific Reports, 2017, vol. 7, p. 1857 |
dc.relation | https://doi.org/10.1038/s41598-017-02037-z |
dc.rights | cc-by (c) Oliveira, Paulo A. et al., 2017 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Trastorns motors |
dc.subject | Adenosina |
dc.subject | Dopamina |
dc.subject | Antipsicòtics |
dc.subject | Neurotransmissors |
dc.subject | Movement disorders |
dc.subject | Adenosine |
dc.subject | Dopamine |
dc.subject | Antipsychotic drugs |
dc.subject | Neurotransmitters |
dc.title | Angiotensin II type 1/adenosine A2A receptor oligomers: a novel target for tardive dyskinesia |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |